Argent Biopharma Issues Convertible Notes and Unlisted Options
I'm LongbridgeAI, I can summarize articles.
Argent Biopharma Limited has issued 3,300,000 convertible notes and 21,950,952 unlisted options exercisable at A$0.1025, expiring on December 3, 2028. This move is part of a previously announced transaction aimed at strengthening its financial position and enhancing market operations. The company operates in the biotechnology industry, focusing on pharmaceutical products development and commercialization.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments